Home /Biblio

Biblio

Found 392 results
Author Keyword Title Type [ Year(Asc)]
2021
M. McCormack, Gaffney, D., Tan, D., Bennet, K., Chávez-Blanco, A., and Plante, M., “The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.”, Int J Gynecol Cancer, 2021.
L. M. Burt, McCormak, M., Lecuru, F., Kanyike, D. M., Bvochora-Nsingo, M., Ndlovu, N., Scott, A. A., Anorlu, R. I., Sharma, V., Plante, M., Nyongesa, C., Tigeneh, W., Fakie, N., Suneja, G., and Gaffney, D. K., “Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management.”, JCO Glob Oncol, vol. 7, pp. 173-182, 2021.
K. M. Schmeler, Pareja, R., Blanco, A. Lopez, Fregnani, J. Humberto, Lopes, A., Perrotta, M., Tsunoda, A. T., Cantú-de-León, D. F., Ramondetta, L. M., Manchana, T., Crotzer, D. R., McNally, O. M., Riege, M., Scambia, G., Carvajal, J. Manuel, Di Guilmi, J., Rendon, G. J., Ramalingam, P., Fellman, B. M., Coleman, R. L., Frumovitz, M., and Ramirez, P. T., “ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.”, Int J Gynecol Cancer, vol. 31, no. 10, pp. 1317-1325, 2021.
C. Callens, Vaur, D., Soubeyran, I., Rouleau, E., Just, P. - A., Guillerm, E., Golmard, L., Goardon, N., Sevenet, N., Cabaret, O., Harter, P., González-Martín, A., Fujiwara, K., Cecere, S. Chiara, Colombo, N., Marth, C., Vergote, I., Maenpaa, J., Pujade-Lauraine, E., and Ray-Coquard, I., “Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.”, J Natl Cancer Inst, vol. 113, no. 7, pp. 917-923, 2021.
C. Falandry, Rousseau, F., Mouret-Reynier, M. - A., Tinquaut, F., Lorusso, D., Herrstedt, J., Savoye, A. - M., Stefani, L., Bourbouloux, E., Sverdlin, R., D’Hondt, V., Lortholary, A., Brachet, P. - E., Zannetti, A., Malaurie, E., Venat-Bouvet, L., Trédan, O., Mourey, L., Pujade-Lauraine, E., and Freyer, G., “Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer”, JAMA Oncology, vol. 7, no. 6, p. 853, 2021.
J. - E. Kurtz, Gebski, V., Sukhin, V., Carey, M., Kong, I., Glasspool, R. M., Berek, J. S., Batista, Mde Paiva, Hall, M., Kim, J. - W., Yeoshoua, E., Fujiwara, N., Nam, B. - H., Polleis, S., Lee, J. - Y., Strojna, A., Farrelly, L., Schwameis, R., Fossati, R., Darlington, A. - S., Lai, C. - H., Wright, A. A., Rosenblat, O., Harter, P., Roxburgh, P., Chowdhury, R. Roy, Chang, T. - C., Paoletti, X., and Friedlander, M., “Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.”, Gynecol Oncol, 2021.
K. Fujiwara, Fujiwara, H., Yoshida, H., Satoh, T., Yonemori, K., Nagao, S., Matsumoto, T., Kobayashi, H., Bourgeois, H., Harter, P., Mosconi, A. Maria, Vazquez, I. Palacio, Reinthaller, A., Fujita, T., Rowe, P., Pujade-Lauraine, E., and Ray-Coquard, I., “Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial”, Journal of Gynecologic Oncology, vol. 32, no. 5, 2021.
A. Poveda, Floquet, A., Ledermann, J. A., Asher, R., Penson, R. T., Oza, A. M., Korach, J., Huzarski, T., Pignata, S., Friedlander, M., Baldoni, A., Park-Simon, T. - W., Tamura, K., Sonke, G. S., Lisyanskaya, A., Kim, J. - H., Filho, E. Abdo, Milenkova, T., Lowe, E. S., Rowe, P., Vergote, I., Pujade-Lauraine, E., Korach, J., Huzarski, T., Byrski, T., Pautier, P., Friedlander, M., Harter, P., Colombo, N., Pignata, S., Scambia, G., Nicoletto, M., Nussey, F., Clamp, A., Penson, R., Oza, A., Velasco, A. Poveda, Rodrigues, M., Lotz, J. - P., Selle, F., Ray-Coquard, I., Provencher, D., Aparicio, A. Prat, Boixader, L. Vidal, Scott, C., Tamura, K., Yunokawa, M., Lisyanskaya, A., Medioni, J., Pécuchet, N., Dubot, C., Rouge, Tde la Mott, Kaminsky, M. - C., Weber, B., Lortholary, A., Parkinson, C., Ledermann, J., Williams, S., Banerjee, S., Cosin, J., Hoffman, J., Penson, R., Plante, M., Covens, A., Sonke, G., Joly, F., Floquet, A., Banerjee, S., Hirte, H., Amit, A., Park-Simon, T. - W., Matsumoto, K., Tjulandin, S., Kim, J. Hoon, Gladieff, L., Sabbatini, R., O'Malley, D., Timmins, P., Kredentser, D., Milagro, N. Laínez, Ginesta, M. Pilar Barr, Martorell, A. Tibau, Lista, A. Gómez De, González, B. Ojeda, Mileshkin, L., Mandai, M., Boere, I., Ottevanger, P., Nam, J. - H., Filho, E., Hamizi, S., Cognetti, F., Warshal, D., Dickson-Michelson, E., Kamelle, S., McKenzie, N., Rodriguez, G., Armstrong, D., Chalas, E., Celano, P., Behbakht, K., Davidson, S., Welch, S., Helpman, L., Fishman, A., Bruchim, I., Sikorska, M., Słowińska, A., Rogowski, W., Bidziński, M., Śpiewankiewicz, B., Herraez, A. Casado, Fernández, C. Mendiola, Gropp-Meier, M., Saito, T., Takehara, K., Enomoto, T., Watari, H., Choi, C. Hun, Kim, B. - G., Kim, J. Weon, Hegg, R., and Vergote, I., “Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial”, The Lancet Oncology, vol. 22, no. 5, pp. 620 - 631, 2021.
A. Tjokrowidjaja, Friedlander, M., Lord, S. J., Asher, R., Rodrigues, M., Ledermann, J. A., Matulonis, U. A., Oza, A. M., Bruchim, I., Huzarski, T., Gourley, C., Harter, P., Vergote, I., Scott, C. L., Meier, W., Shapira-Frommer, R., Milenkova, T., Pujade-Lauraine, E., Gebski, V., and Lee, C. K., “Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy”, European Journal of Cancer, vol. 154, pp. 190 - 200, 2021.
P. Harter, Sehouli, J., Vergote, I., Ferron, G., Reuss, A., Meier, W., Greggi, S., Mosgaard, B. J., Selle, F., Guyon, F., Pomel, C., Lecuru, F., Zang, R., Avall-Lundqvist, E., Kim, J. - W., Ponce, J., Raspagliesi, F., Kristensen, G., Classe, J. - M., Hillemanns, P., Jensen, P., Hasenburg, A., Ghaem-Maghami, S., Mirza, M. R., Lund, B., Reinthaller, A., Santaballa, A., Olaitan, A., Hilpert, F., and Bois, Adu, “Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer”, New England Journal of Medicine, vol. 385, no. 23, pp. 2123 - 2131, 2021.
2020
X. Paoletti, Lewsley, L. - A., Daniele, G., Cook, A., Yanaihara, N., Tinker, A., Kristensen, G., Ottevanger, P. B., Aravantinos, G., Miller, A., Boere, I. A., Fruscio, R., Reyners, A. K. L., Pujade-Lauraine, E., Harkin, A., Pignata, S., Kagimura, T., Welch, S., Paul, J., Karamouza, E., and Glasspool, R. M., “Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis.”, JAMA Netw Open, vol. 3, no. 1, p. e1918939, 2020.
P. Harter, Pautier, P., Van Nieuwenhuysen, E., Reuss, A., Redondo, A., Lindemann, K., Kurzeder, C., Petru, E., Heitz, F., Sehouli, J., Degregorio, N., Wimberger, P., Burges, A., Cron, N., Ledermann, J., Lorusso, D., Paoletti, X., and Marmé, F., “Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).”, Int J Gynecol Cancer, vol. 30, no. 12, pp. 1997-2001, 2020.
J. Pfisterer, Shannon, C. M., Baumann, K., Rau, J., Harter, P., Joly, F., Sehouli, J., Canzler, U., Schmalfeldt, B., Dean, A. P., Hein, A., Zeimet, A. G., Hanker, L. C., Petit, T., Marmé, F., El-Balat, A., Glasspool, R., de Gregorio, N., Mahner, S., Meniawy, T. M., Park-Simon, T. - W., Mouret-Reynier, M. - A., Costan, C., Meier, W., Reinthaller, A., Goh, J. C., L'Haridon, T., Hay, S. Baron, Kommoss, S., Bois, Adu, and Kurtz, J. - E., “Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.”, Lancet Oncol, vol. 21, no. 5, pp. 699-709, 2020.
W. Small, Peltecu, G., Puiu, A., Corha, A., Cocîrṭă, E., Cigăran, R. Gabriela, Plante, M., Jhingran, A., Stang, K., Gaffney, D., Bacon, M., and McCormack, M., “Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference.”, Int J Gynecol Cancer, 2020.
A. Tjokrowidjaja, Lee, C. K., Friedlander, M., Gebski, V., Gladieff, L., Ledermann, J., Penson, R., Oza, A., Korach, J., Huzarski, T., Manso, L., Pisano, C., Asher, R., Lord, S. J., Kim, S. Ik, Lee, J. - Y., Colombo, N., Park-Simon, T. - W., Fujiwara, K., Sonke, G., Vergote, I., Kim, J. - W., and Pujade-Lauraine, E., “Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy”, European Journal of Cancer, vol. 139, pp. 59 - 67, 2020.
I. Ray-Coquard, Harter, P., Lorusso, D., Dalban, C., Vergote, I., Fujiwara, K., Gladieff, L., Lück, H. - J., Floquet, A., Chevalier-Place, A., Schnelzer, A., Pignata, S., Selle, F., Sehouli, J., Brocard, F., Mangili, G., Pautier, P., De Giorgi, U., Provansal, M., and Heudel, P. - E., “Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors”, JAMA Oncology, vol. 6, no. 12, p. 1923, 2020.
I. Rohr, Alavi, S., Richter, R., Keller, M., Chekerov, R., Oskay-Özcelik, G., Heinrich, M., Taskiran, C., Joly, F., Berger, R., Bois, Adu, Gornjec, A., Vergote, I., Achimas-Cadariu, P., Lorusso, D., Maenpaa, J., and Sehouli, J., “Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV).”, Int J Gynecol Cancer, vol. 30, no. 4, pp. 509-514, 2020.
F. Falcone, Maggiore, U. Leone Robe, Di Donato, V., Perrone, A. Myriam, Frigerio, L., Bifulco, G., Polterauer, S., Casadio, P., Cormio, G., Masciullo, V., Malzoni, M., and Greggi, S., “Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study”, Journal of Gynecologic Oncology, vol. 31, 2020.
2019
F. Heitz, Harter, P., Åvall-Lundqvist, E., Reuss, A., Pautier, P., Cormio, G., Colombo, N., Reinthaller, A., Vergote, I., Poveda, A., Ottevanger, P. B., Hanker, L. C., Leminen, A., Alexandre, J., Canzler, U., Sehouli, J., Herrstedt, J., Fiane, B., Merger, M., and A Bois, du, “Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.”, Gynecol Oncol, vol. 152, no. 2, pp. 235-242, 2019.
I. Ray‐Coquard, Cibula, D., Mirza, M. R., Reuss, A., Ricci, C., Colombo, N., Koch, H., Goffin, F., González‐Martin, A., Ottevanger, P. B., Baumann, K., Bjørge, L., Lesoin, A., Burges, A., Rosenberg, P., Gropp‐Meier, M., Harrela, M., Harter, P., Frenel, J. ‐S., Minarik, T., Pisano, C., Hasenburg, A., Merger, M., and Bois, A., “Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer”, International Journal of Cancer, vol. 146, no. 2, pp. 439 - 448, 2019.
G. F. Vercellino, Erdemoglu, E., Lichtenberg, P., Muallem, M. Z., Richter, R., Abu-Rustum, N. R., Plante, M., Lécuru, F., Greggi, S., Monk, B. J., Sagae, S., Denkert, C., Keller, M., Alhakeem, M., Hellriegel, M., Dückelmann, A. M., Chiantera, V., and Sehouli, J., “A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer.”, Arch Gynecol Obstet, 2019.
M. Bagnoli, Shi, T. Yan, Gourley, C., Speiser, P., Reuss, A., Nijman, H. W., Creutzberg, C. L., Scholl, S., Negrouk, A., Brady, M. F., Hasegawa, K., Oda, K., McNeish, I. A., Kohn, E. C., Oza, A. M., MacKay, H., Millan, D., Bennett, K., Scott, C., and Mezzanzanica, D., “Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.”, Cells, vol. 8, no. 3, 2019.
I. Ray-Coquard, Pautier, P., Pignata, S., Pérol, D., González-Martín, A., Berger, R., Fujiwara, K., Vergote, I., Colombo, N., Maenpaa, J., Selle, F., Sehouli, J., Lorusso, D., Alía, E. M. Guerra, Reinthaller, A., Nagao, S., Lefeuvre-Plesse, C., Canzler, U., Scambia, G., Lortholary, A., Marmé, F., Combe, P., de Gregorio, N., Rodrigues, M., Buderath, P., Dubot, C., Burges, A., You, B., Pujade-Lauraine, E., and Harter, P., “Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer”, New England Journal of Medicine, vol. 381, no. 25, pp. 2416 - 2428, 2019.
I. Vergote, A. Bois, du, Floquet, A., Rau, J., Kim, J. - W., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J. - Y., Bologna, A., Carrasco-Alfonso, M. J., and Harter, P., “Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer”, Gynecologic Oncology, vol. 155, no. 2, pp. 186 - 191, 2019.
F. R. Lecuru, McCormack, M., Hillemanns, P., Anota, A., Leitao, M., Mathevet, P., Zweemer, R., Fujiwara, K., Zanagnolo, V., Eriksson, A. Gerda Zahl, Hudson, E., Ferron, G., and Plante, M., “SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study”, International Journal of Gynecologic Cancer, vol. 29, no. 4, pp. 829 - 834, 2019.

Pages